Acute coronary syndromes (ACSs) encompass a spectrum of life-threatening cardiovascular conditions, including unstable angina (UA) and myocardial infarction. While significant progress has been made in the understanding and management of ACS over the years, it has become increasingly evident that sex-based differences play a pivotal role in the pathophysiology, presentation, and outcomes of these conditions. Despite this recognition, the majority of clinical research in the field has historically focused on male populations, leading to a significant knowledge gap in understanding the unique aspects of ACS in women. This review article aims to comprehensively explore and synthesize the current body of literature concerning the sex-specific characteristics of ACS, shedding light on the epidemiology, risk factors, clinical presentation, diagnostic challenges, treatment strategies, and prognosis in women. By elucidating the distinct aspects of ACS in women, this review intends to foster greater awareness and improved clinical management, ultimately contributing to enhanced cardiovascular care for female patients.
ByrneRARosselloXCoughlanJJ, et al.2023ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720-26.
2.
TsaoCWAdayAWAlmarzooqZI, et al.Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022;145:e153-e639.
3.
MoscucciFLavalleFPolitiCCampanaleABaggioGSciomerS. Acute coronary syndrome in women: a new and specific approach is needed. Eur J Prev Cardiol. 2022;29:e305-e308.
4.
VogelBAcevedoMAppelmanY, et al.The Lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet. 2021;397:2385-438.
5.
ColletJPThieleHBarbatoE, et al.2020ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289-367.
6.
CaderFABanerjeeSGulatiM. Sex differences in acute coronary syndromes: a global perspective. J Cardiovasc Dev Dis. 2022;9:239.
7.
MehtaLSBeckieTMDeVonHA, et al.Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 2016;133:916-47.
8.
GroupEUCCSRegitz-ZagrosekVOertelt-PrigioneS, et al.Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37:24-34.
9.
BolegoCPoliAPaolettiR. Smoking and gender. Cardiovasc Res. 2002;53:568-76.
10.
BanerjeeASilverLEHeneghanC, et al.Sex-specific familial clustering of myocardial infarction in patients with acute coronary syndromes. Circ Cardiovasc Genet. 2009;2:98-105.
11.
BucholzEMStraitKMDreyerRP, et al.Editor's Choice-Sex differences in young patients with acute myocardial infarction: a VIRGO study analysis. Eur Heart J Acute Cardiovasc Care. 2017;6:610-22.
12.
HaiderABengsSLuuJ, et al.Sex and gender in cardiovascular medicine: presentation and outcomes of acute coronary syndrome. Eur Heart J. 2020;41:1328-36.
13.
BackholerKPetersSAEBotsSHPeetersAHuxleyRRWoodwardM. Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis. J Epidemiol Community Health. 2017;71:550-7.
14.
GrahamG. Acute coronary syndromes in women: recent treatment trends and outcomes. Clin Med Insights Cardiol. 2016;10:1-10.
15.
VaccarinoVShahAJRooksC, et al.Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med. 2014;76:171-80.
16.
WangZKlipfellEBennettBJ, et al.Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011;472:57-63.
17.
Chella KrishnanKMehrabianMLusisAJ. Sex differences in metabolism and cardiometabolic disorders. Curr Opin Lipidol. 2018;29:404-10.
18.
GomezALuckeyDTanejaV. The gut microbiome in autoimmunity: sex matters. Clin Immunol. 2015;159:154-62.
19.
HonigbergMCZekavatSMAragamK, et al.Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA. 2019;322:2411-21.
20.
RossouwJEPrenticeRLMansonJE, et al.Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465-77.
21.
GrandiSMFilionKBYoonS, et al.Cardiovascular disease-related morbidity and mortality in women with a history of pregnancy complications. Circulation. 2019;139:1069-79.
22.
TanzLJStuartJJWilliamsPL, et al.Preterm delivery and maternal cardiovascular disease in young and middle-aged adult women. Circulation. 2017;135:578-89.
23.
KramerCKCampbellSRetnakaranR. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis. Diabetologia. 2019;62:905-14.
24.
OsibogunOOgunmorotiOMichosED. Polycystic ovary syndrome and cardiometabolic risk: opportunities for cardiovascular disease prevention. Trends Cardiovasc Med. 2020;30:399-404.
25.
FeinbergAP. The key role of epigenetics in human disease prevention and mitigation. N Engl J Med. 2018;378:1323-34.
26.
HaiderABengsSMaredziakM, et al.Heart rate reserve during pharmacological stress is a significant negative predictor of impaired coronary flow reserve in women. Eur J Nucl Med Mol Imaging. 2019;46:1257-67.
27.
MurthyVLNayaMTaquetiVR, et al.Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation. 2014;129:2518-27.
28.
HiteshiAKLiDGaoY, et al.Gender differences in coronary artery diameter are not related to body habitus or left ventricular mass. Clin Cardiol. 2014;37:605-9.
29.
DerooBJKorachKS. Estrogen receptors and human disease. J Clin Invest. 2006;116:561-70.
30.
LanskyAJNgVGMaeharaA, et al.Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC Cardiovasc Imaging. 2012;5:S62-S72.
31.
JohnsonTWRaberLdi MarioC, et al.Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2019;40:2566-84.
32.
LeeTMintzGSMatsumuraM, et al.Prevalence, predictors, and clinical presentation of a calcified nodule as assessed by optical coherence tomography. JACC Cardiovasc Imaging. 2017;10:883-91.
33.
ShawLJMinJKNasirK, et al.Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC consortium. Eur Heart J. 2018;39:3727-35.
34.
TruongQARinehartSAbbaraS, et al.Coronary computed tomographic imaging in women: an expert consensus statement from the Society of Cardiovascular Computed Tomography. J Cardiovasc Comput Tomogr. 2018;12:451-66.
35.
Bairey MerzCNPepineCJWalshMNFlegJL. Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation. 2017;135:1075-92.
36.
HuangFYHuangBTLvWY, et al.The prognosis of patients with nonobstructive coronary artery disease versus normal arteries determined by invasive coronary angiography or computed tomography coronary angiography: a systematic review. Medicine (Baltimore). 2016;95:e3117.
37.
KenkreTSMalhotraPJohnsonBD, et al.Ten-year mortality in the WISE study (women's ischemia syndrome evaluation). Circ Cardiovasc Qual Outcomes. 2017;10:e003863.
38.
KonstREDammanPPellegriniDvan RoyenNMaasAElias-SmaleSE. Diagnostic approach in patients with angina and no obstructive coronary artery disease: emphasising the role of the coronary function test. Neth Heart J. 2021;29:121-8.
39.
AlmeidaAG. MINOCA and INOCA: role in heart failure. Curr Heart Fail Rep. 2023;20:139-150.
40.
SafdarBSpatzESDreyerRP, et al.Presentation, clinical profile, and prognosis of young patients with myocardial infarction with nonobstructive coronary arteries (MINOCA): results from the VIRGO Study. J Am Heart Assoc. 2018;7:e009174.
41.
HayesSNKimESHSawJ, et al.Spontaneous coronary artery dissection: current state of the science: a scientific statement from the american heart association. Circulation. 2018;137:e523-e557.
42.
AdlamDAlfonsoFMaasAVrintsCWritingC. European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection. Eur Heart J. 2018;39:3353-68.
43.
de GrootPCDekkersOMRomijnJADiebenSWHelmerhorstFM. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011;17:495-500.
44.
TalbottEOGuzickDSSutton-TyrrellK, et al.Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol. 2000;20:2414-21.
45.
DragomanMVTepperNKFuRCurtisKMChouRGaffieldME. A systematic review and meta-analysis of venous thrombosis risk among users of combined oral contraception. Int J Gynaecol Obstet. 2018;141:287-94.
46.
TanisBCvan den BoschMAKemmerenJM, et al.Oral contraceptives and the risk of myocardial infarction. N Engl J Med. 2001;345:1787-93.
47.
CurtisKMMohllajeeAPMartinsSLPetersonHB. Combined oral contraceptive use among women with hypertension: a systematic review. Contraception. 2006;73:179-88.
48.
RothAElkayamU. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol. 2008;52:171-80.
49.
ApriglianoGPalloshiAMoriciNFerraresiRBianchiMAnzuiniA. Acute coronary syndrome in pre- and post-partum women - a review. Interv Cardiol. 2013;8:8-13.
LudwigMTolgRRichardtGKatusHADiedrichK. Myocardial infarction associated with ovarian hyperstimulation syndrome. JAMA. 1999;282:632-3.
52.
ColiSMagnoniMMelisurgoG, et al.Myocardial infarction complicating the initial phase of an ovarian stimulation protocol. Int J Cardiol. 2007;115:e56-e57.
DayanNFilionKBOkanoM, et al.Cardiovascular risk following fertility therapy: systematic review and meta-analysis. J Am Coll Cardiol. 2017;70:1203-13.
55.
de LabriolleAGeneeOHeggsLMFauchierL. Acute myocardial infarction following oral methyl-ergometrine intake. Cardiovasc Toxicol. 2009;9:46-8.
56.
TsuiBCStewartBFitzmauriceAWilliamsR. Cardiac arrest and myocardial infarction induced by postpartum intravenous ergonovine administration. Anesthesiology. 2001;94:363-4.
57.
KuczkowskiKM. Myocardial ischemia induced by intramyometrial injection of methylergonovine maleate. Anesthesiology. 2004;100:1043.
58.
LinYHSeowKMHwangJLChenHH. Myocardial infarction and mortality caused by methylergonovine. Acta Obstet Gynecol Scand. 2005;84:1022.
59.
SpauldingCWeberSGuerinFD'HallivilleeP. Coronary artery spasm triggered by oral administration of methylergometrine. Lancet. 1991;338:317.
60.
BuxtonAGoldbergSHirshfeldJW, et al.Refractory ergonovine-induced coronary vasospasm: importance of intracoronary nitroglycerin. Am J Cardiol. 1980;46:329-34.
61.
JangSKBerlacherKHauspurgA. Post-partum myocardial ischemia due to intramuscular methylergonovine-induced coronary vasospasm: case report. BMC Cardiovasc Disord. 2023;23:199.
62.
Roa-DiazZMRaguindinPFBanoALaineJEMukaTGlisicM. Menopause and cardiometabolic diseases: what we (don't) know and why it matters. Maturitas. 2021;152:48-56.
63.
O'KellyACMichosEDShufeltCL, et al.Pregnancy and reproductive risk factors for cardiovascular disease in women. Circ Res. 2022;130:652-72.
64.
MehilliJPresbiteroP. Coronary artery disease and acute coronary syndrome in women. Heart. 2020;106:487-92.
65.
KunadianVChieffoACamiciPG, et al.An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with european society of cardiology working group on coronary pathophysiology & microcirculation endorsed by coronary vasomotor disorders international study group. EuroIntervention. 2021;16:1049-69.
66.
El KhoudarySRAggarwalBBeckieTM, et al.Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142:e506-e532.
67.
Varas-LorenzoCGarcia-RodriguezLAPerez-GutthannSDuque-OliartA. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study. Circulation. 2000;101:2572-78.
68.
BoardmanHMHartleyLEisingaA, et al.Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015;2015:CD002229.
69.
GhadriJRWittsteinISPrasadA, et al.International expert consensus document on takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology. Eur Heart J. 2018;39:2032-46.
70.
CitroROkuraHGhadriJR, et al.Multimodality imaging in takotsubo syndrome: a joint consensus document of the European Association of Cardiovascular Imaging (EACVI) and the Japanese Society of Echocardiography (JSE). Eur Heart J Cardiovasc Imaging. 2020;21:1184-207.
71.
GhadriJRWittsteinISPrasadA, et al.International expert consensus document on takotsubo syndrome (Part II): diagnostic workup, outcome, and management. Eur Heart J. 2018;39:2047-62.
72.
LyonARCitroRSchneiderB, et al.Pathophysiology of takotsubo syndrome: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77:902-21.
73.
MoscaLMochari-GreenbergerHDolorRJNewbyLKRobbKJ. Twelve-year follow-up of American women's awareness of cardiovascular disease risk and barriers to heart health. Circ Cardiovasc Qual Outcomes. 2010;3:120-7.
74.
McSweeneyJCRosenfeldAGAbelWM, et al.Preventing and experiencing ischemic heart disease as a woman: state of the science: a scientific statement from the american heart association. Circulation. 2016;133:1302-31.
75.
KhraishahHAlahmadBAlfaddaghA, et al.Sex disparities in the presentation, management and outcomes of patients with acute coronary syndrome: insights from the ACS QUIK trial. Open Heart. 2021;8:e001470.
76.
StahliBEGebhardCYonekawaK, et al.Gender-related differences in patients presenting with suspected acute coronary syndromes: clinical presentation, biomarkers and diagnosis. Cardiology. 2015;132:189-8.
77.
HealyB. The Yentl syndrome. N Engl J Med. 1991;325:274-6.
78.
KhanNADaskalopoulouSSKarpI, et al.Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med. 2013;173:1863-71.
79.
AraujoCLaszczynskaOVianaM, et al.Sex differences in presenting symptoms of acute coronary syndrome: the EPIHeart cohort study. BMJ Open. 2018;8:e018798.
80.
RoqueDFerreiraJMonteiroSCostaMGilV. Portuguese national registry of acute coronary syndromes I. Understanding a woman's heart: lessons from 14 177 women with acute coronary syndrome. Rev Port Cardiol (Engl Ed). 2020;39:57-72.
81.
Sederholm LawessonSIsakssonRMThylenI, et al.Gender differences in symptom presentation of ST-elevation myocardial infarction - an observational multicenter survey study. Int J Cardiol. 2018;264:7-11.
82.
CardeillacMLefebvreFBaicryF, et al.Symptoms of infarction in women: is there a real difference compared to men? A systematic review of the literature with meta-analysis. J Clin Med. 2022;11:1319.
83.
PelletierRHumphriesKHShimonyA, et al.Sex-related differences in access to care among patients with premature acute coronary syndrome. CMAJ. 2014;186:497-504.
84.
De BacquerDDe BackerGKornitzerM. Prevalences of ECG findings in large population based samples of men and women. Heart. 2000;84:625-33.
85.
BarrabesJAGuptaAPorta-SanchezA, et al.Comparison of electrocardiographic characteristics in men versus women </= 55 years with acute myocardial infarction (a variation in recovery: role of gender on outcomes of young acute myocardial infarction patients substudy). Am J Cardiol. 2017;120:1727-33.
86.
Tamis-HollandJEJneidHReynoldsHR, et al.Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139:e891-e908.
87.
ViraniSSAlonsoABenjaminEJ, et al.Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141:e139-e596.
88.
GhadriJRSarconAJaguszewskiM, et al.Gender disparities in acute coronary syndrome: a closing gap in the short-term outcome. J Cardiovasc Med (Hagerstown). 2015;16:355-62.
89.
CenkoEYoonJKedevS, et al.Sex differences in outcomes after STEMI: effect modification by treatment strategy and age. JAMA Intern Med. 2018;178:632-9.
90.
BergJBjorckLNielsenSLappasGRosengrenA. Sex differences in survival after myocardial infarction in Sweden, 1987-2010. Heart. 2017;103:1625-30.
91.
TownsendNWilsonLBhatnagarPWickramasingheKRaynerMNicholsM. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37:3232-45.
92.
XiZQiuHGuoT, et al.Contemporary sex differences in mortality among patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis. BMJ Open. 2022;12:e053379.
93.
WengerNK. Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation. 2012;126:604-11.
94.
PoonSGoodmanSGYanRT, et al.Bridging the gender gap: insights from a contemporary analysis of sex-related differences in the treatment and outcomes of patients with acute coronary syndromes. Am Heart J. 2012;163:66-73.
95.
RadovanovicDErnePUrbanP, et al.Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart. 2007;93:1369-75.
96.
AroraSStoufferGAKucharska-NewtonAM, et al.Twenty year trends and sex differences in young adults hospitalized with acute myocardial infarction. Circulation. 2019;139:1047-56.
97.
DeVonHASabanKLGarrettDK. Recognizing and responding to symptoms of acute coronary syndromes and stroke in women. J Obstet Gynecol Neonatal Nurs. 2011;40:372-82.
98.
LichtmanJHLeifheit-LimsonECWatanabeE, et al.Symptom recognition and healthcare experiences of young women with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2015;8:S31-S38.
99.
JohanssonIStrombergASwahnE. Factors related to delay times in patients with suspected acute myocardial infarction. Heart Lung. 2004;33:291-300.
100.
LangabeerJR2ndHenryTDFowlerRChampagne-LangabeerTKimJJacobsAK. Sex-based differences in discharge disposition and outcomes for ST-segment elevation myocardial infarction patients within a regional network. J Womens Health (Larchmt). 2018;27:1001-6.
101.
D'OnofrioGSafdarBLichtmanJH, et al.Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study. Circulation. 2015;131:1324-32.
102.
PilgrimTHegDTalK, et al.Age- and gender-related disparities in primary percutaneous coronary interventions for acute ST-segment elevation myocardial infarction. PLoS One. 2015;10:e0137047.
103.
LeeCYHairiNNWan AhmadWA, et al.Are there gender differences in coronary artery disease? The Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry. PLoS One. 2013;8:e72382.
104.
HaoYLiuJLiuJ, et al.Sex differences in In-hospital management and outcomes of patients with acute coronary syndrome. Circulation. 2019;139:1776-85.
105.
SidhuMSLyubarovaRBangaloreSBonacaMP. Challenges of long-term dual antiplatelet therapy use following acute coronary syndromes. Am Heart J. 2022;246:44-64.
106.
BavishiCBangaloreSPatelDChatterjeeSTrivediVTamis-HollandJE. Short and long-term mortality in women and men undergoing primary angioplasty: a comprehensive meta-analysis. Int J Cardiol. 2015;198:123-30.
107.
ConrottoFD'AscenzoFHumphriesKH, et al.A meta-analysis of sex-related differences in outcomes after primary percutaneous intervention for ST-segment elevation myocardial infarction. J Interv Cardiol. 2015;28:132-40.
108.
van der MeerMGNathoeHMvan der GraafYDoevendansPAAppelmanY. Worse outcome in women with STEMI: a systematic review of prognostic studies. Eur J Clin Invest. 2015;45:226-35.
109.
JangJ-SParkY-AJinH-Y, et al.P4661Sex difference in mortality among patients with acute myocardial infarction treated by primary percutaneous coronary intervention: a meta-analysis. Eur Heart J. 2017;38:994-5.
110.
RatcovichHAlkhalilMBeskaB, et al.Sex differences in long-term outcomes in older adults undergoing invasive treatment for non-ST elevation acute coronary syndrome: an ICON-1 sub-study. Int J Cardiol Heart Vasc. 2022;42:101118.
111.
HyunKNegroneARedfernJ, et al.Gender difference in secondary prevention of cardiovascular disease and outcomes following the survival of acute coronary syndrome. Heart Lung Circ. 2021;30:121-7.
112.
BucholzEMButalaNMRathoreSSDreyerRPLanskyAJKrumholzHM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130:757-67.
113.
ZachuraMWilczekKJanionMGasiorMGierlotkaMSadowskiM. Long-term outcomes in men and women with ST-segment elevation myocardial infarction and incomplete reperfusion after a primary percutaneous coronary intervention: a 2-year follow-up. Coron Artery Dis. 2019;30:171-6.
114.
ZhangZFangJGillespieCWangGHongYYoonPW. Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. Am J Cardiol. 2012;109:1097-103.
115.
KumbhaniDJShishehborMHWillisJM, et al.Influence of gender on long-term mortality in patients presenting with non-ST-elevation acute coronary syndromes undergoing percutaneous coronary intervention. Am J Cardiol. 2012;109:1087-91.
116.
MaasAHvan der SchouwYTRegitz-ZagrosekV, et al.Red alert for women's heart: the urgent need for more research and knowledge on cardiovascular disease in women: proceedings of the workshop held in Brussels on gender differences in cardiovascular disease, 29 September 2010. Eur Heart J. 2011;32:1362-68.
117.
LichtmanJHWangYJonesSB, et al.Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR((R)). Am Heart J. 2014;167:376-83.
118.
TavrisDRGallauresiBADeySBrindisRMitchelK. Risk of local adverse events by gender following cardiac catheterization. Pharmacoepidemiol Drug Saf. 2007;16:125-31.
119.
DalyCClemensFLopez SendonJL, et al.Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113:490-8.
120.
AyanianJZEpsteinAM. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 1991;325:221-5.
121.
RathoreSRhysJBuchalterMBGerningNOGrovesPHPennyW. Impact of age on the outcomes of women following percutaneous coronary intervention in the bare-metal stent era. J Interv Cardiol. 2006;19:245-9.
122.
AkhterNMilford-BelandSRoeMTPianaRNKaoJShroffA. Gender differences among patients with acute coronary syndromes undergoing percutaneous coronary intervention in the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). Am Heart J. 2009;157:141-8.
123.
SinghMRihalCSGershBJ, et al.Mortality differences between men and women after percutaneous coronary interventions. A 25-year, single-center experience. J Am Coll Cardiol. 2008;51:2313-20.
124.
MasonPJShahBTamis-HollandJE, et al.An update on radial artery access and best practices for transradial coronary angiography and intervention in acute coronary syndrome: a scientific statement from the American Heart Association. Circ Cardiovasc Interv. 2018;11:e000035.
125.
ValgimigliMFrigoliELeonardiS, et al.Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial. Lancet. 2018;392:835-8.
126.
JollySSYusufSCairnsJ, et al.Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial. Lancet. 2011;377:1409-20.
127.
CantorWJMillerJMHellkampAS, et al.Role of target vessel size and body surface area on outcomes after percutaneous coronary interventions in women. Am Heart J. 2002;144:297-302.
128.
JawitzOKLawtonJSThibaultD, et al.Sex differences in coronary artery bypass grafting techniques: a society of thoracic surgeons database analysis. Ann Thorac Surg. 2022;113:1979-88.
129.
SwaminathanRVFeldmanDNPashunRA, et al.Gender differences in in-hospital outcomes after coronary artery bypass grafting. Am J Cardiol. 2016;118:362-8.
130.
DalenMNielsenSIvertTHolzmannMJSartipyU. Coronary artery bypass grafting in women 50 years or younger. J Am Heart Assoc. 2019;8:e013211.
131.
KuehnemundLLangeSAFeldJ, et al.Sex disparities in guideline-recommended therapies and outcomes after ST-elevation myocardial infarction in a contemporary nationwide cohort of patients over an eight-year period. Atherosclerosis. 2023;375:30-7.
132.
HuberELe PogamMAClairC. Sex related inequalities in the management and prognosis of acute coronary syndrome in Switzerland: cross sectional study. BMJ Med. 2022;1:e000300.
133.
Arias-MendozaAGonzalez-PachecoHAlvarez-SangabrielA, et al.Women with acute myocardial infarction: clinical Characteristics, treatment, and In-hospital outcomes from a Latin American country. Glob Heart. 2023;18:19.
134.
AshrafMJanMFBajwaTKCarnahanRZlochiverVAllaqabandSQ. Sex disparities in diagnostic evaluation and revascularization in patients with acute myocardial infarction-A 15-year nationwide study. J Am Heart Assoc. 2023;12:e027716.
135.
SavageMLHayKMurdochDJ, et al.Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction. Catheter Cardiovasc Interv. 2022;100:520-9.
136.
ChesterRCMinaSALewisBZhangNButterfieldRYangEH. Radial artery access is under-utilized in women undergoing PCI despite potential benefits: Mayo Clinic PCI registry. Catheter Cardiovasc Interv. 2020;95:675-83.
137.
GargiuloGAriottiSVranckxP, et al.Impact of sex on comparative outcomes of radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: data from the randomized MATRIX-access trial. JACC Cardiovasc Interv. 2018;11:36-50.
138.
PatelKNMajmundarMVasudevaR, et al.Impact of gender, race, and insurance status on inhospital management and outcomes in patients with COVID-19 and ST-elevation myocardial infarction (a Nationwide Analysis). Am J Cardiol. 2023;198:14-25.
139.
VarmaYJenaNKArseneCPatelKSuleAAKrishnamoorthyG. Disparities in the management of non-ST-segment elevation myocardial infarction in the United States. Int J Cardiol. 2023;383:132-9.
140.
AlkhouliMAlqahtaniFJneidHAl HajjiMBoubasWLermanA. Age-Stratified sex-related differences in the incidence, management, and outcomes of acute myocardial infarction. Mayo Clin Proc. 2021;96:332-41.
141.
O'DonoghueMBodenWEBraunwaldE, et al.Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis. JAMA. 2008;300:71-80.
142.
ManziMVBuccheriSJollySS, et al.Sex-related differences in thrombus burden in STEMI patients undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2022;15:2066-76.
143.
KimSRBaeSLeeJY, et al.Gender disparities in prevalence by diagnostic criteria, treatment and mortality of newly diagnosed acute myocardial infarction in Korean adults. Sci Rep. 2023;13:4120.
144.
DafaallaMRashidMVan SpallHGC, et al.Women are less likely to survive ami presenting with out-of-hospital cardiac arrest: a nationwide study. Mayo Clin Proc. 2022;97:1608-18.
145.
HayMStehliJMartinC, et al.Sex differences in optimal medical therapy following myocardial infarction according to left ventricular ejection fraction. Eur J Prev Cardiol. 2020;27:2348-50.
146.
PetersSAEColantonioLDZhaoH, et al.Sex differences in high-intensity statin use following myocardial infarction in the United States. J Am Coll Cardiol. 2018;71:1729-37.
147.
BotsSHIniaJAPetersSAE. Medication adherence after acute coronary syndrome in women compared with men: a systematic review and meta-analysis. Front Glob Womens Health. 2021;2:637398.
148.
BytyciIPensonPEMikhailidisDP, et al.Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43:3213-23.
149.
DelewiRVogelRFWilschutJM, et al.Sex-stratified differences in early antithrombotic treatment response in patients presenting with ST-segment elevation myocardial infarction. Am Heart J. 2023;258:17-26.
KourtiOKonstantasOFarmakisI, et al.Potent P2Y12 inhibitors versus clopidogrel to predict adherence to antiplatelet therapy after an acute coronary syndrome: insights from IDEAL-LDL. Rev Cardiovasc Med. 2022;23:81.
152.
MauriLKereiakesDJYehRW, et al.Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2014;371:2155-66.
153.
Al RaisiSProttyMRaposeiras-RoubinS, et al.Ticagrelor versus prasugrel in acute coronary syndrome: sex-specific analysis from the RENAMI Registry. Minerva Cardiol Angiol. 2021;69:408-16.
154.
LauESBraunwaldEMurphySA, et al.Potent P2Y(12) inhibitors in men versus women: a collaborative meta-analysis of randomized trials. J Am Coll Cardiol. 2017;69:1549-59.
LeeBLeeSJKimBK, et al.Sex differences in outcomes of ticagrelor therapy with or without aspirin after percutaneous coronary intervention in patients with acute coronary syndrome: a post hoc secondary analysis of the TICO randomized clinical trial. Arterioscler Thromb Vasc Biol. 2023;43:e218-e226.
157.
ValgimigliMGaregnanoFBancaM, et al.P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials. BMJ. 2021;373:n1332.
158.
AlexopoulosDLianosIVlachakisPSfantouDDragonaVMVarlamosC. De-Escalation of treatment with oral P2Y12 receptor inhibitors: current status and perspectives. J Cardiovasc Pharmacol Ther. 2019;24:304-14.
159.
GrossLKupkaDTrenkD, et al.Gender and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients: the TROPICAL-ACS gender substudy. Thromb Haemost. 2019;119:1527-38.
160.
KimCJParkMWKimMC, et al.Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial. Lancet. 2021;398:1305-16.
161.
ColvinCLPoudelBBressAP, et al.Race/ethnic and sex differences in the initiation of non-statin lipid-lowering medication following myocardial infarction. J Clin Lipidol. 2021;15:665-73.
162.
SourijCAzizFTripoltNJ, et al.Effects of empagliflozin in women and men with acute myocardial infarction - an analysis from the EMMY trial. Hellenic J Cardiol. 2023.
163.
ChenWRShenXQZhangY, et al.Effects of liraglutide on left ventricular function in patients with non-ST-segment elevation myocardial infarction. Endocrine. 2016;52:516-26.
164.
ChenWRTianFChenYD, et al.Effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction. Int J Cardiol. 2016;208:109-14.
165.
WooJSKimWHaSJ, et al.Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study. Arterioscler Thromb Vasc Biol. 2013;33:2252-60.
